attempted a trial of diazoxide in a patient with primary pulmonary hypertension. The outcome suggests caution in the use of this drug in such patients.
A 39-year-old woman with severe pulmonary hypertension with no apparent cause had previously undergone unsuccessful trials of oxygen, nitroprusside, isoprenaline, and tolazoline during cardiac catheterisation. In August 1978 diazoxide was injected into the main pulmonary artery, and haemodynamic measurements were taken 5 minutes after each dose using the procedure described by Wang et al. (1978) . The results are given in the Diazoxide administered by peripheral vein has been found to lower pulmonary artery pressure and resistance in patients with pulmonary hypertension (Just and Stein, 1969) . The intravenous solution is highly alkaline (pH 11 6) and 
